Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - Commentary

Mult Scler. 2017 Apr;23(4):508-509. doi: 10.1177/1352458516674368. Epub 2016 Oct 11.

Author

Daniel Ontaneda¹

Affiliation

¹ Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

PMID: 27729553
DOI: 10.1177/1352458516674368

No abstract available

Publication types

Comment

MeSH terms

Humans
Multiple Sclerosis, Chronic Progressive*
Outcome Assessment, Health Care*